[144] Spok Holdings, Inc SEC Filing

Rhea-AI Filing Summary

Form 144 filed for Spok Holdings, Inc. (SPOK) reporting a proposed sale of 11,000 common shares through Charles Schwab with an aggregate market value of $197,780.00, to be sold approximately on 08/25/2025 on Nasdaq. The shares were acquired as stock grants on 01/01/2025 (14,958 shares granted) and paid as equity compensation. The filer previously sold 10,000 common shares on 08/04/2025 for gross proceeds of $184,868.00. The notice includes the usual signature attestations that the seller is not aware of undisclosed material adverse information.

Insights

Securities Analyst

TL;DR: Insider intends to sell a small position from recent stock grants; transaction size appears immaterial to SPOK capitalization.

The filing shows a proposed sale of 11,000 common shares valued at $197,780 and a prior sale of 10,000 shares for $184,868. Based solely on the filing, these sales arise from equity compensation granted on 01/01/2025. Relative to the reported 20,590,924 shares outstanding, the proposed sale represents roughly 0.05% of outstanding shares, indicating limited direct market impact. There is no earnings or operational data in the filing; conclusions are restricted to the insider selling activity and acquisition method noted.

Corporate Governance Expert

TL;DR: The notice documents routine disposition of recently granted shares and includes standard attestation language required by Rule 144 filings.

The filer discloses acquisition via stock grants and identifies the broker and proposed sale date. The filing includes the mandatory representation that the seller is unaware of undisclosed material adverse information and the criminal-liability warning. No governance actions, executive departures, or indications of unusual trading plans are disclosed in the provided content.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Charles Schwab Corp 3000 Schwab Way Westlake TX 76262	11000	197780.00	20590924	08/25/2025	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/01/2025	Stock Grants	Issuer			14958	01/01/2025	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Michael Wallace 3000 Technology Driev Suite 400 Plano TX 75074	Common	08/04/2025	10000	184868.00

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the SPOK Form 144 report?

The Form 144 reports a proposed sale of 11,000 common shares of Spok Holdings (SPOK) valued at $197,780.00, to be sold about 08/25/2025 on Nasdaq.

How were the shares acquired according to the filing?

The filing states the shares were acquired as stock grants on 01/01/2025 and the payment type is listed as equity compensation.

Has the filer sold other SPOK shares recently?

Yes. The filing discloses a sale of 10,000 common shares on 08/04/2025 with gross proceeds of $184,868.00.

Who is the broker handling the proposed sale?

The broker named in the filing is Charles Schwab Corp located at 3000 Schwab Way, Westlake, TX.

Does the Form 144 indicate undisclosed material information about SPOK?

By signing the notice the filer represents they do not know any material adverse information about the issuer that has not been publicly disclosed; no undisclosed material information is stated in the filing.